These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2538251)

  • 21. Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen.
    Gandara DR; Wold H; Perez EA; Deisseroth AB; Doroshow J; Meyers F; McWhirter K; Hannigan J; De Gregorio MW
    J Natl Cancer Inst; 1989 May; 81(10):790-4. PubMed ID: 2541260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
    Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisplatin and novobiocin in the treatment of non-small cell lung cancer. A Southwest Oncology Group study.
    Ellis GK; Crowley J; Livingston RB; Goodwin JW; Hutchins L; Allen A
    Cancer; 1991 Jun; 67(12):2969-73. PubMed ID: 1646065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association Study.
    White DR; Powell BL; Craig JB; Stuart RK; Schnell FM; Goldklang GA; Atkins JN; Jackson DV; Richards F; Muss HB
    Cancer; 1990 Apr; 65(8):1700-3. PubMed ID: 2156598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancer.
    Georgiadis MS; Schuler BS; Brown JE; Kieffer LV; Steinberg SM; Wilson WH; Takimoto CH; Kelley MJ; Johnson BE
    J Clin Oncol; 1997 Feb; 15(2):735-43. PubMed ID: 9053499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
    Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X
    Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study.
    Hazuka MB; Crowley JJ; Bunn PA; O'Rourke M; Braun TJ; Livingston RB
    J Clin Oncol; 1994 Sep; 12(9):1814-20. PubMed ID: 8083705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party.
    Klastersky J; Sculier JP; Dabouis G; Bureau G; Libert P; Ravez P; Vandermoten G; Thiriaux J; Lecomte J; Cordier R
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):20-4. PubMed ID: 2154855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05).
    Zappa F; Droege C; Betticher D; von Moos R; Bubendorf L; Ochsenbein A; Gautschi O; Oppliger Leibundgut E; Froesch P; Stahel R; Hess T; Rauch D; Schmid P; Mayer M; Crowe S; Brauchli P; Ribi K; Pless M;
    Lung Cancer; 2012 Dec; 78(3):239-44. PubMed ID: 23009726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cytostatic treatment of patients with advanced non-small cell lung cancer].
    Zych J; Radzikowska E; Załeska J; Obłakowski P; Słodkowska J; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 1998; 66(1-2):73-8. PubMed ID: 9658884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
    Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
    Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combination chemotherapy with Taxol and cisplatin for 57 patients with non-small cell lung cancer by intraartery and intravenous infusion].
    Zhao Y; Wang SM; Zhang J
    Ai Zheng; 2002 Dec; 21(12):1365-7. PubMed ID: 12520750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phase-I clinical study of KW-2307 combined with cisplatin in non-small cell lung cancer patients].
    Yamamoto M; Ariyoshi Y; Hasegawa K; Kobayashi K; Fukuoka M; Kurita Y; Sakuma A; Furuse K; Niitani H
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):993-9. PubMed ID: 8002639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.
    Khuri FR; Rigas JR; Figlin RA; Gralla RJ; Shin DM; Munden R; Fox N; Huyghe MR; Kean Y; Reich SD; Hong WK
    J Clin Oncol; 2001 May; 19(10):2626-37. PubMed ID: 11352954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen: a multicenter phase II study.
    Makrantonakis P; Ziotopoulos P; Agelidou A; Polyzos A; Ziras A; Chandrinos V; Vossos A; Kalykaki A; Androulakis N; Geroyianni A; Georgoulias V;
    Lung Cancer; 2006 Jul; 53(1):85-90. PubMed ID: 16720058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A weekly cisplatin-based induction regimen for extensive non-small cell lung cancer. A Southwest Oncology Group study.
    Higano CS; Crowley J; Livingston RB; Goodwin JW; Barlogie B; Stuckey WJ
    Cancer; 1991 May; 67(10):2439-42. PubMed ID: 1849785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized phase II trial of two different schedules of docetaxel plus cisplatin as first-line therapy in advanced nonsmall cell lung cancer.
    Park SH; Choi SJ; Kyung SY; An CH; Lee SP; Park JW; Jeong SH; Cho EK; Shin DB; Hoon Lee J
    Cancer; 2007 Feb; 109(4):732-40. PubMed ID: 17211861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose cisplatin and vinblastine infusion with or without radiation therapy in patients with advanced non-small-cell lung cancer.
    Blumenreich MS; Woodcock TM; Gentile PS; Barnes GR; Jose B; Sherrill EJ; Richman SP; Epremian BE; Kubota TT; Allegra JC
    J Clin Oncol; 1987 Nov; 5(11):1725-30. PubMed ID: 2824706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancer.
    Kim YH; Kim JS; Choi YH; In KH; Park HS; Hong DS; Jeong TJ; Lee YY; Nam E; Lee SN; Lee KS; Kim HK
    Int J Clin Oncol; 2002 Apr; 7(2):114-9. PubMed ID: 12018108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.